glutamine has been researched along with Alpha Virus Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baxter, VK; Braxton, AM; Glowinski, R; Griffin, DE; Potter, MC; Slusher, BS | 1 |
Alt, J; Baxter, VK; Griffin, DE; Mathey, RW; Potter, MC; Rojas, C; Slusher, BS | 1 |
Baxter, VK; Griffin, DE; Manivannan, S; Schultz, KL; Slusher, BS | 1 |
3 other study(ies) available for glutamine and Alpha Virus Infections
Article | Year |
---|---|
Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.
Topics: Alphavirus Infections; Animals; Antiviral Agents; Diazooxonorleucine; Encephalomyelitis; Glutamine; Humans; Interferon-gamma; Male; Mice; Mice, Inbred C57BL; Sindbis Virus | 2017 |
Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine.
Topics: Alphavirus Infections; Animals; Antimetabolites, Antineoplastic; Behavior, Animal; Diazooxonorleucine; Disease Models, Animal; Encephalitis, Viral; Enzyme-Linked Immunosorbent Assay; Glutamine; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Motor Activity; Sindbis Virus | 2015 |
Protective Effects of Glutamine Antagonist 6-Diazo-5-Oxo-l-Norleucine in Mice with Alphavirus Encephalomyelitis.
Topics: Alphavirus; Alphavirus Infections; Animals; Cells, Cultured; Central Nervous System; Cytokines; Diazooxonorleucine; Encephalitis; Encephalitis, Viral; Encephalomyelitis; Female; Glutamine; Lymphocytes; Mice; Mice, Inbred C57BL; Paralysis; Sindbis Virus; Virus Replication | 2016 |